18F-FDG PET/CT in lung adenosquamous carcinoma and its correlation with clinicopathological features and prognosis

Objective Lung adenosquamous carcinoma (ASC) is a rare histological subtype of non-small cell lung cancer (NSCLC). Due to its rarity, the studies about 18 F-FDG PET/CT in this kind of pulmonary tumor were quite limited. Thus, this study investigated 18 F-FDG PET/CT findings in ASC and its correlation with clinicopathological features and clinical outcomes. Methods Preoperative 18 F-FDG PET/CT findings and parameters of maximum standard uptake value (SUV max ), metabolic tumor volume and total lesion glycolysis of primary lesion (MTV-P, TLG-P), combination of primary lesion and metastases (MTV-C, TLG-C), and clinicopathological features were retrospectively investigated in patients with ASC. Moreover, progression-free survival (PFS) was also analyzed. Results All 41 patients (25 men; 16 women; age: 60 ± 7 years) had single ASC with the mean diameter of 33 ± 14 mm. Six lesions were located centrally and 35 peripherally. Serum tumor markers were abnormally increased sporadically. Twenty-two cases were at TNM stage I, 9 at II, and 10 at III. The primary tumors were FDG-avid in all cases, with the average SUV max of 11.5 ± 6.0. SUV max was significantly associated with tumor location, size, and TNM stage ( P